5 February 2020
| Gwyn Samuel Williams
|
EYE - General
Over the past two years I have attended quite a number of medical educational seminars and ‘workshops’ and have been a bit shocked at how out of kilter with reality the world of education seems to be now. It seems...
Adele sings a song called Hello, which is about a mythical phonecall she makes to an ex-boyfriend about how different life is now compared to when they used to date. The chorus line repeated many times is “Hello from the...
Google Glass I recently attended a demo of the Google Glass technology (at the TEDx Salford conference). For those who have not come across Glass, it a wearable computer developed by Google. In essence it is a very small computer...
Our AI & Oculomics co-editor, Nima Ghadiri, sat down with Abraham Olvera-Barrios from Moorfields and Anand Rajesh from the University of Washington to discuss their recent international study into retinal pigmentation and its wider clinical, technological and academic applications. Can...
3 February 2026
| Gwyn Samuel Williams
|
EYE - General
In the past, a system existed for when unexpected circumstances arose, with trainees from one part of the country being able to apply to relocate to another part without losing out on training time. This was mainly because of marriage,...
Treatment practice in the management of neovascular age-related macular degeneration (AMD) and diabetic macular oedema (DMO) illustrate increasing adoption of patient-tailored treatment approaches based on initial diagnosis and regular monitoring of imaging and visual outcomes in routine clinical care. The...
The author discusses the first quality standard for serious eye disorders from NICE and takes a look at new care models for enhanced service delivery. Patient backlogs pose risks to patient safety, with research showing that people are losing sight...
Rod McNeil provides an update on a promising bispecific antibody recently approved for treatment of neovascular age-related macular degeneration (nAMD) and diabetic macular oedema (DMO) and considers emerging developments in biosimilars to established anti-vascular endothelial growth factor (anti-VEGF) therapies, including...
Bolton North East MP Mark Logan visited SpaMedica’s new building, The View, which accommodates 180 company employees, including 40 recruited in the last year.
20 years of Vision Care for Homeless People, and the 18,000+ people who have been helped to better vision through the regional drop-in clinics, were celebrated by a host of volunteers, charity founders and generous donors from the optical community last week.